Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Russell Branum (NPI 1629065685)

Field	Value
Entity Type	Individual
Organization	Russell Branum
Address	1501 S Waldron Rd
City	Fort Smith
State	AR
ZIP	72903
Taxonomy	Rheumatology Physician
NPI Enumerated	October 4, 2005

Payer Source	Total Paid
Medicare	$3.1M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: Total Medicare revenue is $3.1M while Medicaid activity is absent (no Medicaid billing on file). The lack of any Medicaid billing on record means analyses of this entity should treat Medicare as the principal payer and not expect Medicaid claims to materially affect utilization or contracting strategies.

Revenue is highly concentrated in a small set of biologic/injectable therapies: the precomputed top 3 Medicare codes by revenue account for 48.0% of this provider's total Medicare revenue. Those top three codes are J0129 ($691.4K revenue, 22.5%), J9312 ($416K revenue, 13.6%), and J1602 ($365K revenue, 11.9%), indicating the practice depends substantially on on‑site administration of high‑cost injectable agents.

The CPT/HCPCS mix points to an infusion‑center or infusion‑intensive rheumatology practice model: multiple high‑revenue J‑codes (J0129, J9312, J1602, J3262, J1745) appear alongside chemotherapy/infusion administration codes (96413, 96401, 96415). This combination suggests regular, supervised IV/subcutaneous biologic and infusion sessions rather than a purely office‑visit consult practice.

Competitive standing on key biologics is mixed: several of the major drug codes sit at high national percentiles but are described as "typical, unremarkable volume" for those codes (for example J0129 ranks #118 of 1221 providers nationally, 90th percentile; J9312 ranks #35 of 317, 89th percentile; J1602 ranks #124 of 1041, 88th percentile). At the same time, J0897 is flagged as "notably above typical national volume" (95th percentile), indicating pockets where this provider bills materially more than most peers for specific agents.

Outpatient evaluation-and-management activity is unusually large: 99214 shows 2.3K claims and $196.3K revenue (6.4% of Medicare revenue) and is labeled an "extreme outlier, far above typical national volume for this code." That level of E/M billing implies a heavy ongoing management caseload of established patients in addition to infusion visits.

The practice provides a significant set of ancillary diagnostics and imaging onsite or via tightly linked services: high‑volume lab and imaging codes include 80053 ($28.9K), 85025 ($22.9K), 82306 ($10.3K), 77080 ($9.1K) and imaging codes 73630 ($15K) and 73120 ($14.1K), with several of these entries reported at very high national percentiles (for example 80053 and 85025 at 98th percentile, 73630 and 73120 at 100th percentile for their respective metrics). These patterns are consistent with a practice that manages bone health, inflammatory labs, and routine diagnostics in support of rheumatology care.

Chemotherapy/infusion administration codes are notable relative to peers: 96413 ($74.7K) and 96401 ($41.1K) are both described as "notably above typical national volume" (98th and 97th percentiles, respectively), and 96415 ($6.5K) is similarly "notably above typical" (96th percentile). These flags reinforce that infusion throughput and time‑based infusion services are a material part of revenue and operational capacity.

The provider has long tenure in the Medicare program, with NPI enumerated on 2005-10-04 (~21 years ago), indicating an established regional presence. Combined with $3.1M in lifetime Medicare revenue and the code mix above, this suggests a stable, Medicare‑focused rheumatology practice that prioritizes biologic infusion services and associated diagnostics rather than Medicaid or pediatric populations.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

54 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	20,950	$30	$691.4K
J9312	Injection, rituximab, 10 mg	6,500	$60	$416K
J1602	Injection, golimumab, 1 mg, for intravenous use	33,180	$10	$365K
J3262	Injection, tocilizumab, 1 mg	70,640	$10	$353.2K
J0897	Injection, denosumab, 1 mg	15,240	$20	$274.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	63,200	$1	$252.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,340	$80	$196.3K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,410	$30	$166.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	830	$90	$74.7K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	810	$50	$41.1K

Showing 1–10 of 54

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 54 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Russell Branum — 12 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

54 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	5	20	8,960	$30	$532.4K
J9312	3	10	6,500	$60	$393.8K
J0717	7	10	66,400	$1	$278.1K
J3262	2	10	28,550	$1	$208.6K
J1602	1	10	15,300	$10	$185.4K
J1745	2	10	3,150	$30	$102.3K
J0897	10	160	2,580	$20	$89.7K
96413	9	80	380	$90	$36.6K
99214	10	4,300	130	$70	$18.8K
86481	1	10	20	$100	$13K

Showing 1–10 of 54

Related Providers

Other providers that share a Tax Identification Number (TIN) with Russell Branum, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$7M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$6.6M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$5.1M
Arcare	KY	Federally Qualified Health Center (FQHC)	$0	$4.4M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$3.9M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$3.9M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$3.6M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$3M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$3M
Arcare	AR	Federally Qualified Health Center (FQHC)	$0	$3M

Nearby Providers

Other providers in the same ZIP code as Russell Branum, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Gregory Kistler Treatment Center, Inc.	AR	Voluntary or Charitable Agency	$0	$28.3M
Bost, Inc.	AR	Counselor	$0	$25.9M
Mercy Clinic Fort Smith Communities	AR	Multi-Specialty Clinic/Center	$0	$24.1M
Mercy Hospital Fort Smith	AR	General Acute Care Hospital	$0	$22.5M
Western Arkansas Counseling & Guidance Center, Inc	AR	Community/Behavioral Health Agency	$0	$21.3M
Arkansas Family Supports, Inc.	AR	In Home Supportive Care Agency	$0	$15.6M
Kids Unlimited Learning Academy Of Ft. Smith	AR	Rehabilitation Clinic/Center	$0	$10.5M
1 Of A Kind In Home Care And Medical Services LLC	AR	In Home Supportive Care Agency	$0	$7M
The Gregory Kistler Treatment Center, Inc.	AR	Voluntary or Charitable Agency	$0	$6.5M
Little Hands At Play Therapy, LLC	AR	Pediatric Occupational Therapist	$0	$4.9M

Russell Branum — Billing Profile & Reimbursement Data

Sign up for Russell Branum — Billing Profile & Reimbursement Data policy alerts

Russell Branum — Billing Profile & Reimbursement Data

Sign up for Russell Branum — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References